Can J Anesth/J Can Anesth (2017) 64:904–907 DOI 10.1007/s12630-017-0915-z EDITORIALS Marie-Claude Gregoire, MD, MSc, FRCPC Received: 25 May 2017 / Accepted: 13 June 2017 / Published online: 19 June 2017 Canadian Anesthesiologists’ Society 2017 In the midst of a busy medical practice in Canada, it is easy highly trained staff. They used a standard initial dose to to forget that access to postoperative pain relief has not simplify the dosing protocol, and they changed doses based always been universal in our country. In this issue of the on a simple treatment algorithm. The authors note that the Journal, Tuchscherer et al. remind us that most patients in cost per injection of subcutaneous ketamine is Can $0.40. developed countries take certain entitlements for granted, To put this cost in context, the average the Rwandan’s which, unfortunately, are far from accessible to all. Their hourly salary in 2012 was 450 Rwandan francs (Can study explored the potential use of subcutaneous ketamine $0.75). The use of ketamine represents a creative, for pain following major surgery in Rwanda; their results apparently safe, efﬁcacious, and inexpensive treatment showed that ketamine appears to be safe within the range of for postoperative pain, which is clinically
Canadian Journal of Anesthesia/Journal canadien d'anesthésie – Springer Journals
Published: Jun 19, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera